Dexcom vs. Insulet: Which Diabetes Stock is a Better Buy in 2026?
Diabetes management is evolving rapidly as the industry innovates to treat the more than 40 million Americans with type 1 or type 2 diabetes. Deciding between two leaders in monitoring and treatment, DexCom (NASDAQ:DXCM) and Insulet (NASDAQ:PODD), requires a close look at